Antibiotics help in preventing and treating infections and increasing life expectancy globally.
Globally, many people's lives are being threatened by the emergence of antimicrobial …

Traditionally, antifungal resistance (AFR) has received much less attention compared with
bacterial resistance to antibiotics. However, global changes, pandemics, and emerging new …

Introduction The threat of new, emerging, and multidrug-resistant microbes is increasing
which has created the necessity for new antimicrobials. In this regard, nanotechnology can …

Emerging and uncommon Candida species have been reported as an increasing cause of
invasive Candida infections (ICI). We aim to systematize the global epidemiology associated …

Recognition of risk factors for hospital-acquired infections (HAI) in patients with COVID-19 is
warranted. We aimed to describe factors associated with the development of HAI in patients …

Invasive fungal infections, notably candidemia, have been associated with COVID-19. The
epidemiology of candidemia has significantly changed during the COVID-19 pandemic. We …

The earliest documented COVID-19 case caused by the SARS-CoV-2 coronavirus occurred
in Wuhan, China, in December 2019. Since then, several SARS-CoV-2 mutants have rapidly …

Candida species cause life-threatening infections with high morbidity and mortality rates and
their resistance to conventional therapy is closely linked to biofilm formation. Thus, the …

Outbreaks of multidrug-resistant Candida auris infections, associated with a mortality rate of
30% to 60%, are of serious global concern. Candida auris demonstrates high transmission …

The treatment of fungal infections presents significant challenges due to the lack of
standardized diagnostic procedures, a restricted range of antifungal treatments, and the risk …